BioNTech CEO Ugur Sahin said Friday that while there were concerns the Pfizer-BioNTech vaccine may not be as effective against the new Omicron COVID-19 variant, it was possible to quickly adapt the current shot to combat the variant.
COVID-19
COVID-19: BioNTech CEO says it’s possible to quickly adapt Pfizer vaccine for Omicron
More Videos
-
U.S. presidency ‘has been the honour of my life,’ Biden says during White House toast
-
‘Shattered the system’: Conservatives question Trudeau’s immigration policy change
-
The Morning Show: October 18
-
Eva Mendes cereal controversy: What you need to know about food dye
-
CRA fires 330 employees for inappropriately claiming CERB
-
New trial treatment hopes to restore ability to smell after COVID-19
You are viewing an Accelerated Mobile Webpage.
View Original Article